Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON56481Completed
Trial of esketamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Maastricht University. Primary endpoints: Number of self-reported intrusive memories over 7 days and Distress of self-reported intrusive memories over 7 days. Started Mar 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON56481.